XML 31 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning Balance at Dec. 31, 2019 $ (3,642)   $ 1     $ (3,643)
Beginning Balance, Shares at Dec. 31, 2019     15,640,133      
Issuance of Series A and Series B convertible preferred stock, net of issuance costs   $ 44,731        
Issuance of Series A and Series B convertible preferred stock, net of issuance costs, Shares   21,710,814        
Conversion of convertible debt and interest to Series A convertible preferred stock   $ 500        
Conversion of convertible debt and interest to Series A convertible preferred stock, Shares   301,685        
Settlement of bifurcated conversion liability   $ 125        
Exercises of stock options and vesting of restricted stock 1     $ 1    
Exercises of stock options and vesting of restricted stock, Shares     317,688      
Stock-based compensation 450     450    
Unrealized gain (loss) on investments 156       $ 156  
Net loss (8,280)         (8,280)
Ending Balance at Dec. 31, 2020 $ (11,315)   $ 1 451 156 (11,923)
Ending Balance, Shares at Dec. 31, 2020 22,012,499 22,012,499        
Ending Balance at Dec. 31, 2020 $ 45,356 $ 45,356        
Ending Balance, Shares at Dec. 31, 2020     15,957,821      
Issuance of Series A and Series B convertible preferred stock, net of issuance costs   $ 124,712        
Issuance of Series A and Series B convertible preferred stock, net of issuance costs, Shares   19,083,979        
Preferred stock converted into shares of common stock 170,068   $ 4 170,064    
Preferred stock converted into shares of common stock, Shares   (41,096,478)        
Preferred stock converted into shares of common stock   $ (170,068)        
Preferred stock converted into shares of common stock, Shares     25,212,548      
Initial public offering of common shares, net of $21,728 of issuance costs 254,271   $ 1 254,270    
Initial public offering of common shares, net of $21,728 of issuance costs, Shares     13,800,000      
Exercises of stock options and vesting of restricted stock 156     156    
Exercises of stock options and vesting of restricted stock, Shares     460,101      
Issuance of common stock under employee stock purchase plan 194     194    
Issuance of common stock under employee stock purchase plan, Shares     11,456      
Stock-based compensation 4,689     4,689    
Unrealized gain (loss) on investments (400)       (400)  
Net loss (35,533)         (35,533)
Ending Balance at Dec. 31, 2021 $ 382,130   $ 6 $ 429,824 $ (244) $ (47,456)
Ending Balance, Shares at Dec. 31, 2021 0          
Ending Balance, Shares at Dec. 31, 2021     55,441,926